Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above

Authors not listed

Chinese Academy of Medical Sciences · 2021

Dysbiosis Human Randomized controlled trial

Abstract

This is a randomized, double-blinded, placebo controlled phase III clinical trial to evaluate the efficacy, safety and immunogenicity of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above after 2-dose schedule.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-25 MST

Cite this

APA

Anonymous. (2021). A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above. <em>Chinese Academy of Medical Sciences</em>. https://clinicaltrials.gov/study/NCT04659239

Vancouver

Anonymous. A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above. Chinese Academy of Medical Sciences. 2021.

BibTeX

@misc{anon2021ARando, title = {A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above}, author = {Anonymous}, journal = {Chinese Academy of Medical Sciences}, year = {2021}, }